Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia

We present a female patient who received an allogeneic bone marrow transplantation for primary refractory Philadelphia-positive acute biphenotypic leukemia. Since leukemic blasts were persistently present in peripheral blood and bone marrow, in spite of the evidence for engraftment of male donor hem...

Full description

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 18; no. 1; pp. 257 - 261
Main Authors AZUNO, Y, KANEKO, T, KAMEI, S, ZAITSU, Y, TAKEUCHI, Y, OKA, Y, KAKU, K, NISHIMURA, M, OKUYA, S, NAKAI, K, NOMIYAMA, J, MORI, K, OKAFUJI, K, OKUBO, M, MATSUTANI, A
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.07.1996
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We present a female patient who received an allogeneic bone marrow transplantation for primary refractory Philadelphia-positive acute biphenotypic leukemia. Since leukemic blasts were persistently present in peripheral blood and bone marrow, in spite of the evidence for engraftment of male donor hematopoiesis, we performed donor leukocyte transfusions and discontinued immunosuppression. An initial complete remission was obtained 15 weeks after allogeneic bone marrow transplantation, and lasted for 24 weeks. We concluded that the prominent mechanism for the eradication of the refractory leukemic clone in the patient was the graft-versus-leukemia effect.
AbstractList We present a female patient who received an allogeneic bone marrow transplantation for primary refractory Philadelphia-positive acute biphenotypic leukemia. Since leukemic blasts were persistently present in peripheral blood and bone marrow, in spite of the evidence for engraftment of male donor hematopoiesis, we performed donor leukocyte transfusions and discontinued immunosuppression. An initial complete remission was obtained 15 weeks after allogeneic bone marrow transplantation, and lasted for 24 weeks. We concluded that the prominent mechanism for the eradication of the refractory leukemic clone in the patient was the graft-versus-leukemia effect.
Author NISHIMURA, M
ZAITSU, Y
TAKEUCHI, Y
KAMEI, S
NOMIYAMA, J
MORI, K
KANEKO, T
OKA, Y
AZUNO, Y
KAKU, K
OKUBO, M
OKAFUJI, K
MATSUTANI, A
NAKAI, K
OKUYA, S
Author_xml – sequence: 1
  givenname: Y
  surname: AZUNO
  fullname: AZUNO, Y
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 2
  givenname: T
  surname: KANEKO
  fullname: KANEKO, T
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 3
  givenname: S
  surname: KAMEI
  fullname: KAMEI, S
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 4
  givenname: Y
  surname: ZAITSU
  fullname: ZAITSU, Y
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 5
  givenname: Y
  surname: TAKEUCHI
  fullname: TAKEUCHI, Y
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 6
  givenname: Y
  surname: OKA
  fullname: OKA, Y
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 7
  givenname: K
  surname: KAKU
  fullname: KAKU, K
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 8
  givenname: M
  surname: NISHIMURA
  fullname: NISHIMURA, M
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 9
  givenname: S
  surname: OKUYA
  fullname: OKUYA, S
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 10
  givenname: K
  surname: NAKAI
  fullname: NAKAI, K
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 11
  givenname: J
  surname: NOMIYAMA
  fullname: NOMIYAMA, J
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 12
  givenname: K
  surname: MORI
  fullname: MORI, K
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 13
  givenname: K
  surname: OKAFUJI
  fullname: OKAFUJI, K
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 14
  givenname: M
  surname: OKUBO
  fullname: OKUBO, M
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
– sequence: 15
  givenname: A
  surname: MATSUTANI
  fullname: MATSUTANI, A
  organization: Department of Internal Medicine, Yamaguchi Rosai Hospital, Yamaguchi, Japan
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3143877$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/8832032$$D View this record in MEDLINE/PubMed
BookMark eNo9kMtOwzAQRS1UVFrgE5BmwTaSE9t5LBFvqRIbWKOJM6GGxI5sh6pfyG9h1IrVjGbu3Hs0a7awztIJW-WyKjMlSrVgK16UdSZE2ZyxdQifnOdScrVky7oWBRfFiv3cOes8DDR_Ob2PBNGjDf0cjLMB0HbQmaCdjcbOGNMQXA9mHGfrwjxNnkJAGwNEB6i3hr4pHYGxJhocwNNowp8VYB_JAw6D-yBLRkObaGFE793ukDkNyegQYZIeptSTjbAzcQuTN0m7T4a9Rx1dalHPCfcPPIXgBTvtcQh0eazn7O3h_vX2Kdu8PD7f3myyqRAqZg12xNs2V0J0VScbwUl2eZ5XrahRl6Q09ryRvJWq45iLSqIWSmrSddEoXYhzdnXwneZ2pO79CPZ-fGjaXx_3GDQOidZqE_5lIpeirirxC5D6iUU
CODEN BMTRE9
ContentType Journal Article
Copyright 1996 INIST-CNRS
Copyright_xml – notice: 1996 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1476-5365
EndPage 261
ExternalDocumentID 8832032
3143877
Genre Journal Article
Case Reports
GroupedDBID ---
-Q-
.55
.XZ
0R~
23N
2WC
36B
39C
3V.
4.4
406
53G
5GY
5RE
6J9
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AADWK
AANZL
AAPBV
AATNV
AAUGY
AAWBL
AAYFA
AAYJO
AAZLF
ABAWZ
ABDBF
ABLJU
ABPTK
ABUWG
ACBMV
ACBRV
ACBYP
ACGFO
ACGFS
ACIGE
ACIWK
ACKTT
ACMJI
ACPRK
ACRQY
ACTTH
ACVWB
ADBBV
ADFRT
ADHDB
ADMDM
ADQMX
ADYYL
AEDAW
AEFTE
AEJRE
AENEX
AEVLU
AEXYK
AFFNX
AFKRA
AFNRJ
AFRAH
AFSHS
AGAYW
AGEZK
AGGBP
AGHAI
AHMBA
AHSBF
AILAN
AJCLW
AJDOV
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMRJV
AMYLF
ASPBG
AVWKF
AXYYD
AZFZN
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CCPQU
CS3
DIK
DNIVK
DPUIP
DU5
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
ESX
EX3
F5P
FDQFY
FEDTE
FERAY
FIZPM
FRP
FSGXE
FYUFA
GX1
HCIFZ
HZ~
IAO
IH2
IHR
IHW
INH
INR
IQODW
ITC
IWAJR
J5H
JSO
JZLTJ
KQ8
M1P
M7P
N9A
NAO
NQJWS
NXXTH
NYICJ
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNT
RNTTT
SNX
SNYQT
SOHCF
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UDS
UKHRP
X7M
ZA5
ZGI
ZXP
~8M
AACDK
AASML
AAYZH
ABAKF
ABJNI
ABZZP
ACAOD
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AIGIU
ALIPV
CGR
CUY
CVF
ECM
EIF
FIGPU
HMCUK
HVGLF
LGEZI
LOTEE
NADUK
NPM
ID FETCH-LOGICAL-p235t-9ade0bb1533d7d4930e4d1117b38ac6e5caf0940b45d0a1374ac354cec8295c23
ISSN 0268-3369
IngestDate Tue Oct 15 23:15:43 EDT 2024
Sun Oct 29 17:08:25 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Blood product
HLA-System
Discontinuous
Chemoprophylaxis
Transfusion
Leukocyte
Leukemia
Major histocompatibility system
Homograft
Prevention
Bone marrow
Graft
Remission
Mixed lineage
Human
Immunopathology
Acute
Related donor
Graft versus host reaction
Malignant hemopathy
Case study
Treatment
Young adult
Immunosuppressive agent
Histocompatibility
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p235t-9ade0bb1533d7d4930e4d1117b38ac6e5caf0940b45d0a1374ac354cec8295c23
PMID 8832032
PageCount 5
ParticipantIDs pubmed_primary_8832032
pascalfrancis_primary_3143877
PublicationCentury 1900
PublicationDate 1996-07-01
PublicationDateYYYYMMDD 1996-07-01
PublicationDate_xml – month: 07
  year: 1996
  text: 1996-07-01
  day: 01
PublicationDecade 1990
PublicationPlace Basingstoke
PublicationPlace_xml – name: Basingstoke
– name: England
PublicationTitle Bone marrow transplantation (Basingstoke)
PublicationTitleAlternate Bone Marrow Transplant
PublicationYear 1996
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
SSID ssj0014405
Score 1.5246173
Snippet We present a female patient who received an allogeneic bone marrow transplantation for primary refractory Philadelphia-positive acute biphenotypic leukemia....
SourceID pubmed
pascalfrancis
SourceType Index Database
StartPage 257
SubjectTerms Adult
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biological and medical sciences
Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis
Bone Marrow - pathology
Bone Marrow Transplantation - immunology
Clone Cells - immunology
Clone Cells - pathology
Combined Modality Therapy
Drug Resistance, Neoplasm
Fatal Outcome
Female
Graft vs Host Disease - drug therapy
Graft vs Host Disease - etiology
Graft vs Host Reaction
Humans
Immunosuppressive Agents - administration & dosage
Immunosuppressive Agents - adverse effects
Leukocyte Transfusion
Male
Medical sciences
Methylprednisolone - administration & dosage
Methylprednisolone - adverse effects
Neoplastic Cells, Circulating
Neoplastic Stem Cells - immunology
Neoplastic Stem Cells - pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood
Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Prednisolone - administration & dosage
Prednisolone - adverse effects
Recurrence
Remission Induction
Tissue Donors
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Transplantation, Homologous
Title Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia
URI https://www.ncbi.nlm.nih.gov/pubmed/8832032
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9swEBdpYaMvY__Kuq3jHvYWPBzLspzH_S8b7V5ayFuRZAVCWtskdiH9OPsy-1q7kxQ7Sbex7cUYy7IE97N0d_rdHWOvpaKsahqNHDm2UWqzJNI8ERFZIzITqPBLih0-PctOLtIvEzEZDL5vsJbaRr8xt7-MK_kfqeIzlCtFyf6DZLuP4gO8R_niFSWM17-S8YeqrBbDK9vOK7NqLNV7QC20XTpyG3nEKea2oloQbacZziggpFq2ta9-QiwYVD-JUmlv6ChhOCM6kUv3jxBY9nXE6YQeZ2JnZqirknivlL7Rj1lfqTLQFmf4_jpbq_fy1iGhBe7FC1fdZ4XDET2BJo6DqK2D5T98GpXhd4p8G6iwzu2mD-O2dRXEh51e_lWVdl5tkcDPyNt23bq6Sr0P-Nu8XaneBVyEgMCs48qul8kkyyPOfcGXu2t6h92wQPt02BvgqK8dOnJc2uLgat1OwB1a9tgeHxFp9POkIxHRybjwXjw_hwN2L7xOJFu1xP9s6guk7JgtTn05f8geBLsD3noQPWIDWz5m908Ds-IJ--GwBB2WYBNLgFiCHSxBNYW7WIKmgoAl7AQBS9BhCRyWoMcSEJbACxx2BI7dQUHAEhCWIGAJeiyBwxKssfSUXXz6eP7-JApFPqI64aKJxqqwsdZkdhSySMc8tmmBG7DUPFcms8KoKeV41KkoYjXiMlWGi9RYkydjYRJ-yPZLnOkzBpmOdVIkMXbgKRqN2ow4Wuu460iKP7dH7HhLJJdhzpccjYZcyiN26EXUNQRZPv9dwwt20EPyJdtvFq09RiW10a8cTn4Cxw2k4Q
link.rule.ids 315,783,787
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Donor+leukocyte+transfusions+and+discontinuation+of+immunosuppressants+to+achieve+an+initial+remission+after+allogeneic+bone+marrow+transplantation+in+a+patient+with+primary+refractory+acute+leukemia&rft.jtitle=Bone+marrow+transplantation+%28Basingstoke%29&rft.au=Azuno%2C+Y&rft.au=Kaneko%2C+T&rft.au=Nishimura%2C+M&rft.au=Okuya%2C+S&rft.date=1996-07-01&rft.issn=0268-3369&rft.volume=18&rft.issue=1&rft.spage=257&rft_id=info%3Apmid%2F8832032&rft.externalDocID=8832032
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0268-3369&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0268-3369&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0268-3369&client=summon